Template:Androgen replacement therapy formulations and dosages used in men
Nowadays, Template:Androgen replacement therapy formulations and dosages used in men is a topic that has gained great relevance in society. Whether it's its impact on the economy, its influence on popular culture, or its role in history, Template:Androgen replacement therapy formulations and dosages used in men has captured the attention of people of all ages and backgrounds. Since its emergence, Template:Androgen replacement therapy formulations and dosages used in men has been the subject of debate and analysis, with conflicting opinions giving rise to passionate discussions. In this article, we will explore different aspects of Template:Androgen replacement therapy formulations and dosages used in men and its impact on various areas of daily life. Through deep analysis and detailed research, we will seek to better understand the importance of Template:Androgen replacement therapy formulations and dosages used in men and how it has shaped the world we know today.
Notes: Men produce about 3 to 11 mg testosterone per day (mean 7 mg/day in young men). Footnotes:a = Never marketed. b = No longer used and/or no longer marketed. Sources:
^Nieschlag, E.; Freischem, C. W. (1982). "Androgen Therapy in Hypogonadism and Infertility". In J. Bain; Wolf-Bernhard Schill; L. Schwarzstein (eds.). Treatment of Male Infertility. pp. 103–115. doi:10.1007/978-3-642-68223-0_8. ISBN978-3-642-68223-0.
^Alan J. Wein; Louis R. Kavoussi; Andrew C. Novick; Alan W. Partin, Craig A. Peters (28 September 2011). Campbell-Walsh Urology. Elsevier Health Sciences. pp. 739–740. ISBN1-4557-2298-7.
^Basaria, Shehzad; Wahlstrom, Justin T.; Dobs, Adrian S. (2001). "Anabolic-Androgenic Steroid Therapy in the Treatment of Chronic Diseases". The Journal of Clinical Endocrinology & Metabolism. 86 (11): 5108–5117. doi:10.1210/jcem.86.11.7983. ISSN0021-972X.
^Morales, A.; Lunenfeld, B. (2009). "Androgen replacement therapy in aging men with secondary hypogonadism". The Aging Male. 4 (3): 151–162. doi:10.1080/tam.4.3.151.162. ISSN1368-5538.
^Srinivas-Shankar, Upendram; Wu, Frederick CW (2006). "Drug Insight: testosterone preparations". Nature Clinical Practice Urology. 3 (12): 653–665. doi:10.1038/ncpuro0650. ISSN1743-4270.
^Tan, Robert S.; Bransgrove, Linda (2015). "Testosterone replacement therapy". Postgraduate Medicine. 103 (5): 247–256. doi:10.3810/pgm.1998.05.491. ISSN0032-5481.
^Zitzmann, M; Nieschlag, E (2000). "Hormone substitution in male hypogonadism". Molecular and Cellular Endocrinology. 161 (1–2): 73–88. doi:10.1016/S0303-7207(99)00227-0. ISSN0303-7207.
^Kaufman, Joel M. (2004). "Evolution of delivery systems for testosterone administration". Current Sexual Health Reports. 1 (3): 109–114. doi:10.1007/s11930-004-0025-0. ISSN1548-3584.
^Leichtnam, Marie-Laure; Rolland, Hervé; Wüthrich, Patrick; Guy, Richard H. (2006). "Testosterone Hormone Replacement Therapy: State-of-the-Art and Emerging Technologies". Pharmaceutical Research. 23 (6): 1117–1132. doi:10.1007/s11095-006-0072-5. ISSN0724-8741.
^Morales, Alvaro (2005). "Androgen replacement therapy in the hypogonadal ageing man". Expert Opinion on Pharmacotherapy. 4 (6): 911–918. doi:10.1517/14656566.4.6.911. ISSN1465-6566.
^Byrne, M. M.; Nieschlag, E. (2014). "Testosterone replacement therapy in male hypogonadism". Journal of Endocrinological Investigation. 26 (5): 481–489. doi:10.1007/BF03345206. ISSN0391-4097.
^Nieschlag, Eberhard (2015). "Current topics in testosterone replacement of hypogonadal men". Best Practice & Research Clinical Endocrinology & Metabolism. 29 (1): 77–90. doi:10.1016/j.beem.2014.09.008. ISSN1521-690X.
^Surampudi, Prasanth; Swerdloff, Ronald S; Wang, Christina (2014). "An update on male hypogonadism therapy". Expert Opinion on Pharmacotherapy. 15 (9): 1247–1264. doi:10.1517/14656566.2014.913022. ISSN1465-6566.
^Buvat, Jacques; Maggi, Mario; Guay, André; Torres, Luiz Otavio (2013). "Testosterone Deficiency in Men: Systematic Review and Standard Operating Procedures for Diagnosis and Treatment". The Journal of Sexual Medicine. 10 (1): 245–284. doi:10.1111/j.1743-6109.2012.02783.x. ISSN1743-6095.
^Hafez, B.; Hafez, E. S. E. (2009). "Andropause: Endocrinology, Erectile Dysfunction, and Prostate Pathophysiology". Archives of Andrology. 50 (2): 45–68. doi:10.1080/aan.50.2.45.68. ISSN0148-5016.
^Llahana, Sofia (2019). "Testosterone Therapy in Adult Men with Hypogonadism". Advanced Practice in Endocrinology Nursing. pp. 885–902. doi:10.1007/978-3-319-99817-6_46.
^Lunenfeld, Bruno; Oettel, Michael (2009). "Therapeutic potential of testosterone gels". Aging Health. 5 (2): 227–245. doi:10.2217/ahe.09.6. ISSN1745-509X.